ArticleBone marrow transplantation2021

Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status.

Yoshimitsu Shimomura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.